## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

## 




## 


## 

## 



## 

## 

## 

## 



## 



## 

## 

## 

## 





## 

## 



## 



## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

|**Note**<br>**Income**<br>Donations and<br>4<br>legacies<br>Income from<br>4<br>charitable activities<br>Income fromother<br>4<br>trading activities<br>Investment income<br>3<br>**Total income**<br>**Expenditure**<br>Costofraising<br>funds<br>Expenditure on<br>6<br>charitable activities<br>**Total expenditure**<br>Realised and<br>9<br>unrealised gain/<br>(loss)on<br>investments<br>Netincome/<br>(expenditure)<br>Net movement on<br>funds<br>**Total funds**<br>**brought forward**<br>**Total funds carried**<br>**forward**|<br>**Unrestricted**<br>**Restricted**<br>**Total Funds**<br>**Unrestricted**<br>**Restricted**<br>**Total Funds**<br>**Funds**<br>**Funds**<br>**Year Ended**<br>Funds<br>**Funds**<br>**Year Ended**<br>**£'000**<br>**£'000**<br>**31 March**<br>**£'000**<br>**£'000**<br>**31 March**<br>**2022**<br>**2021**<br>**£'000**<br>**£'000**<br>2,128<br>2,264<br>4,392<br>2,207<br>980<br>3,187<br>1,326<br>90<br>1,416<br>1,026<br>23<br>1,049<br>722<br>722<br>422<br>422<br>103<br>103<br>71<br>71<br>**4,279**<br>**2,354**<br>**6,633**<br>**3,726**<br>**1,003**<br>**4,729**|
|---|---|
||1,722<br>1,722<br>1,237<br>1,237<br>3,749<br>2,199<br>5,948<br>3,196<br>1,434<br>4,630|
||**5,471**<br>**2,199**<br>**7,670**<br>**4,433**<br>**1,434**<br>**5,867**|
||252<br>252<br>666<br>666|
||**(940)**<br>**155**<br>**(785)**<br>**(41)**<br>**(431)**<br>**(472)**|
||**(940)**<br>**155**<br>**(785)**<br>**(41)**<br>**(431)**<br>**(472)**|
||**5,634**<br>**2,899**<br>**8,533**<br>**5,675**<br>**3,330**<br>**9,005**|
||**4,694**<br>**3,054**<br>**7,748**<br>**5,634**<br>**2,899**<br>**8,533**|





## 

|Note<br>**FixedAssets**<br>Tangible fixed assets<br>8<br>Investments<br>9<br>**Total fixedassets**<br>**Currentassets**<br>Stock<br>10<br>Debtors<br>11<br>Cashat bank and in hand<br>12<br>**Total currentassets**<br>**Liabilities**<br>Creditors falling due within one year<br>13<br>**Netcurrent assets/ (liabilities)**<br>**Totalassetslesscurrent liabilities**<br>Creditors: Amounts falling due after<br>more than one year<br>13<br>**Netassets**<br>**Funds**<br>Unrestricted income funds<br>14<br>Restricted income funds<br>14<br>**Total funds**|**Group**<br>**2022**<br>**£'000**<br>43<br>8,852<br>**8,895**<br>36<br>621<br>2,959<br>**3,616**<br>(4,763)<br>**(1,147)**<br>**7,748**<br>4,694<br>3,054|**Charity**<br>**2022**<br>**£'000**<br>8,852<br>**8,852**<br>849<br>2,779<br>**3,628**<br>(4,732)<br>**(1,104)**<br>**7,748**<br>4,694<br>3,054|**Group**<br>**2021**<br>**£'000**<br>26<br>7,828<br>**7,854**<br>34<br>273<br>2,026<br>**2,333**<br>(1,654)<br>**679**<br>**8,533**<br>5,634<br>2,899|**Charity**<br>**2021**<br>**£'000**<br>7,828|
|---|---|---|---|---|
|||||**7,828**|
|||||448<br>1,906|
|||||**2,354**|
|||||(1,649)|
|||||**705**|
|||||**8,533**<br>5,634<br>2,899|
||**7,748**|**7,748**|**8,533**|**8,533**|





## 

||Note|**Year Ended**|**Year Ended**||**Year Ended**|**Year Ended**||
|---|---|---|---|---|---|---|---|
|||**31 March 2022**|||**31 March 2021**|||
|||**£000**|**£000**||**£000**|**£000**||
|**Cashflows from operating activities:**||||||||
|Net cash (usedin)/provided by operating<br>activities|||1,622|||(1,042)||
|**Cashflows from investing activities:**||||||||
|Dividends andinterestfrominvestments|3|103|||71|||
|Paymentstoacquire tangible fixed assets|8|(20)||||||
|Paymentstoacquire investments|9|(1,454)|||(3,426}|||
|Receiptsfromsalesofinvestments|9|682|||590|||
|Net cash provided by investing activities|||(689}|||(2,766)||
|lncrease/(Decrease) incashand cash equivalents||||933||(3,807)||
|Cashand cash equivalents atthestartoftheyear|||2,026|||5,833||
|Cashand cash equivalents attheendoftheyear|||2,959|||2,026||
|**Reconciliation of net incometonetcashflowfrom operating**||**activities**||||||
|Netincome/(expenditure)forthereporting period(asper||||(785)|||(472)|
|theStatementofFinancial Activities)||||||||
|Adjustments for:||||||||
|Dividends andintereston investments||||(103}|||(71)|
|(Gains)/losses on investments||||(252)|||(666)|
|Depreciation||||3|||3|
|(lncrease)/decrease in stock||||(2)|||(7)|
|(lncrease)/decrease in debtors||||(348)|||198|
|Increase/decrease in creditors||||3,109|||(27)|
|Net cashprovided/(used in) by operating activities||||**1,622**||**(1,042)**||
|**Analysisofcashandcashequivalents**||||||||
|Bankcurrentaccounts||||227|||177|
|Bank deposit accounts||||2,732||1,849||
|**Totalcashandcashequivalents**||||**2,959**||**2,026**||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

|**Grossincomingresources**<br>Costofraising funds<br>Costofcharitable activities<br>**Net (outgoing)/ incomingresources**<br>Realised and unrealisedgains/(losses) on<br>investments<br>Total funds brought forward<br>**Total funds carried forward**<br>**Representedby:**<br>Restricted income funds<br>Unrestricted income funds|**Year ended 31**<br>**March 2022**<br>£'000<br>**6,287**<br>(1,376)<br>(5,948)<br>**(1,037}**<br>252<br>8,533<br>**7,748**<br>3,054<br>4,694<br>**7,748**|**Year ended 31**<br>**March 2021**<br>£'000<br>**5,172**<br>(1,059)<br>(4,630)|
|---|---|---|
|||**(517}**|
|||666<br>8,384|
|||**8,533**|
|||2,899<br>5,634|
|||**8,533**|



## 

|Turnover<br>Operating costs<br>**Operating profit**<br>**Year ended 31**<br>**March 2022**<br>£'000<br>764<br>(346)<br>**418**|**Year ended 31**<br>**March 2021**<br>£'000<br>430<br>(178)|
|---|---|
||**252**|



## 

|**YearEnded**<br>**31 March 2022**<br>£000<br>Interest<br>**28**<br>Dividends<br>75<br>**TOTAL**<br>**103**|**YearEnded**<br>**31 March 2021**<br>£000<br>12<br>59<br>71|
|---|---|





## 

## 

|**Donations and legacies:**<br>Donations from individuals<br>Corporate donations<br>Donations from groups&<br>associations<br>Donations in memoriam<br>Grant income<br>Legacies<br>Gifts in kind<br>**Total donations and legacies**<br>**Income from charitable**<br>**activities:**<br>Fundraising events<br>Lottery<br>**Total income from charitable**<br>**activities**<br>**Income fromothertrading**<br>**activities:**<br>Saleofpromotional items<br>**Total income from other**<br>**trading activities**|**Unrestricted**<br>**Restricted**<br>**Total Year**<br>**Unrestricted**<br>**Restricted**<br>**Total Year**<br>**£000**<br>**£000**<br>**Ended31**<br>**£000**<br>**£000**<br>**Ended31**<br>**March2022**<br>**March2021**<br>**£000**<br>**£000**<br>867<br>513<br>1,380<br>873<br>239<br>1,112<br>312<br>373<br>685<br>214<br>92<br>306<br>50<br>9<br>59<br>102<br>41<br>143<br>82<br>46<br>128<br>52<br>10<br>62<br>77<br>1,322<br>1,399<br>200<br>598<br>798<br>543<br>1<br>544<br>204<br>204<br>197<br>197<br>562<br>562<br>**2,128**<br>**2,264**<br>**4,392**<br>**2,207**<br>**980**<br>**3,187**<br>659<br>90<br>749<br>336<br>23<br>359<br>667<br>667<br>690<br>690<br> <br>**1,326**<br>**90**<br>**1,416**<br>**1,026**<br>**23**<br>**1,049**<br>722<br>722<br>422<br>**422**<br>**722**<br>**722**<br>**422**<br>**422**|**Unrestricted**<br>**Restricted**<br>**Total Year**<br>**Unrestricted**<br>**Restricted**<br>**Total Year**<br>**£000**<br>**£000**<br>**Ended31**<br>**£000**<br>**£000**<br>**Ended31**<br>**March2022**<br>**March2021**<br>**£000**<br>**£000**<br>867<br>513<br>1,380<br>873<br>239<br>1,112<br>312<br>373<br>685<br>214<br>92<br>306<br>50<br>9<br>59<br>102<br>41<br>143<br>82<br>46<br>128<br>52<br>10<br>62<br>77<br>1,322<br>1,399<br>200<br>598<br>798<br>543<br>1<br>544<br>204<br>204<br>197<br>197<br>562<br>562<br>**2,128**<br>**2,264**<br>**4,392**<br>**2,207**<br>**980**<br>**3,187**<br>659<br>90<br>749<br>336<br>23<br>359<br>667<br>667<br>690<br>690<br> <br>**1,326**<br>**90**<br>**1,416**<br>**1,026**<br>**23**<br>**1,049**<br>722<br>722<br>422<br>**422**<br>**722**<br>**722**<br>**422**<br>**422**|
|---|---|---|
|||**2,128**<br>**2,264**<br>**4,392**<br>**2,207**<br>**980**<br>**3,187**<br>659<br>90<br>749<br>336<br>23<br>359<br>667<br>667<br>690<br>690|
||||
|||**1,326**<br>**90**<br>**1,416**<br>**1,026**<br>**23**<br>**1,049**<br>722<br>722<br>422<br>**422**|
||||
|||**722**<br>**722**<br>**422**<br>**422**|



## 

|Salaries<br>Bankand service charges<br>Investment management<br>costs<br>Trust services<br>**TOTAL**|**Year**<br>**Allocated to**<br>**Allocated**<br>**Year**<br>**Allocatedto**<br>**Allocated**<br>**Ended31**<br>**Governance**<br>**to**<br>**Ended31**<br>**Governance**<br>**to**<br>**March2022**<br>**£'000**<br>**Support**<br>**March2021**<br>**£'000**<br>**support**<br>**Total**<br>**Costs**<br>**Total**<br>**costs**<br>**£'000**<br>**£'000**<br>**£'000**<br>**£'000**<br>407<br>(128)<br>279<br>370<br>(119)<br>251<br>45<br>45<br>30<br>30<br>36<br>36<br>22<br>22<br>54<br>54<br>49<br>49|
|---|---|
||542<br>(128)<br>414<br>471<br>(119)<br>352|





## 

## 

|**AreaofExpenditure**<br>**Year Ended31March2022**<br>Patient Welfare<br>**Year Ended31March2021**<br>Patient Welfare<br>**Auditors' Remuneration**<br>Auditors' remunerationfor<br>audit<br>Feespayabletoauditors<br>fornon-audit services|**Support**<br>**Charges**<br>**£'000**<br>378<br>330<br>**Governance**<br>**£'000**<br>128<br>119<br>**Investment**<br>**Management**<br>**£'000**<br>36<br>22<br>**Total**<br>**£'000**<br>542<br>471<br>**Year ended**<br>**31March**<br>**2022**<br>**£'000**<br>10<br>1<br>11<br>**Year ended**<br>**31March**<br>**2021**<br>**£'000**<br>10<br>1<br>11|**Support**<br>**Charges**<br>**£'000**<br>378<br>330<br>**Governance**<br>**£'000**<br>128<br>119<br>**Investment**<br>**Management**<br>**£'000**<br>36<br>22<br>**Total**<br>**£'000**<br>542<br>471<br>**Year ended**<br>**31March**<br>**2022**<br>**£'000**<br>10<br>1<br>11<br>**Year ended**<br>**31March**<br>**2021**<br>**£'000**<br>10<br>1<br>11|
|---|---|---|
|||11<br>11|



## 

|**Area of**<br>**expenditure:**<br>Magic (Patient<br>welfare&Other)<br>Research&<br>Innovation<br>Equipment<br>ParkCampus<br>**Total**|**Grant Funding**<br>**Support**<br>**to Alder Hey**<br>**Costs**<br>**Children'sNHS**<br>**£000**<br>**Foundation**<br>**Trust£000**<br>1,696<br>542<br> <br>370<br>340<br>3,000<br>**Total Yearto**<br>**31March**<br>**2022**<br>**£000**<br>2,238<br>370<br>340<br>3,000<br>**Grant Fundingto**<br>**Alder Hey**<br>**Children'sNHS**<br>**Foundation Trust**<br>**£000**<br>1,141<br>1,186<br>961<br>871<br>**Support**<br>**Costs**<br>**£000**<br>471<br>**Total Yearto**<br>**31March**<br>**2021**<br>**£000**<br>1,612<br>1,186<br>961<br>871|
|---|---|
||**5,406**<br>**542**<br>**5,948**<br>**4,159**<br>**471**<br>**4,630**|





## 

## 

|**Year Ended 31 March 2022**<br>Salaries and Wages<br>Social Security Costs<br>Other Pension Costs<br>**Total StaffCosts**<br>Average Numberof<br>Employees<br>**Year Ended 31 March 2021**<br>Salaries and Wages<br>SociaI Security Costs<br>Other Pension Costs<br>Total StaffCosts<br>Average Numberof<br>Employees|**Fundraising**<br>&**Publicity**<br>**£000**<br>585<br>54<br>12<br>**651**|**Support**<br>**Costs**<br>**£000**<br>251<br>21<br>7<br>**279**|**Governance**<br>**£000**<br>112<br>13<br>3<br>**128**|**Total**<br>**£000**<br>947<br>88<br>22<br>**1,057**|
|---|---|---|---|---|
||20<br>505<br>47<br>22<br>**574**|8<br>225<br>18<br>8<br>**251**|2<br>104<br>12<br>3<br>**119**|30<br>834<br>77<br>33<br>**944**|
||17|8|2|**27**|



|||**2022**|**2021**|
|---|---|---|---|
|£70,000|to£80,000|1|1|
|£60,000|to£70,000|1||



|key personnel wereasfollows:||
|---|---|
|Chief Executive|HeadofCorporate Partnerships|
|DirectorofFinance&Operations|HeadofCommunityFundraising|
|HeadofPhilanthropy|HeadofMarketing|





## 

|**Group**<br>**Cost**<br>At 1 April 2021<br>Additions<br>**At 31 March 2022**<br>**Depreciation**<br>At 1 April 2021<br>Chargeforthe year<br>**At 31 March 2022**<br>**NetBookValue**<br>**At 31 March 2022**<br>At31March 2021||**2022**<br>**2021**<br>**LeaseholdImprovements**<br>**Total**<br>**LeaseholdImprovements**<br>**Total**<br>**£'000**<br>**£'000**<br>**£'000**<br>**£'000**<br>30<br>30<br>30<br>30<br>20<br>20|
|---|---|---|
|||so<br>so<br>30<br>30<br>4<br>4<br>1<br>1<br>3<br>3<br>3<br>3|
|||**7**<br>7<br>**4**<br>**4**<br>**43**<br>**43**<br>**26**<br>**26**<br>26<br>26<br>29<br>29|



## 

|**Investments**|||
|---|---|---|
||**2022**|**2021**|
||**£'000**|**£'000**|
|**Group**|||
|Investment portfolio|8,852|7,828|
||8,852|**7.828**|
|**Charity**|||
|Investment portfolio|8.852|7,828|
||**8.852**|**7.828**|



## 

|Market Value at31March 2021<br>Additions at cost<br>Disposals<br>Net gain on revaluation<br>Market Value carried forward<br>Historic cost at31March 2022||**2022**<br>**2021**<br>**£'000**<br>**£'000**<br>7,828<br>4,326<br>1,454<br>3,426<br>(682)<br>(590)<br>252<br>666|
|---|---|---|
|||8,852<br>7,828<br>7,683<br>6,887|
||||





## 

## 

## 

|UKEquities<br>Overseas Equities<br>FixedInterest<br>Cashheldaspartofinvestment<br>portfolio<br>Alternatives<br>Total|<br>**Held**<br>**inUK**<br>**£000**<br>1,443<br>527<br>3,942<br>1,014<br>**6,926**<br>**Held**<br>**OutsideUK**<br>**£000**<br>1,873<br>53<br>**1,926**<br>**Totalat**<br>**31 March**<br>**2022**<br>**£000**<br>1,443<br>1,873<br>580<br>3,942<br>1,014<br>**8,852**<br>**Held**<br>**inUK**<br>**£000**<br>1,145<br>460<br>3,774<br>1,000<br>**6,379**<br>**Held**<br>**OutsideUK**<br>**£000**<br>1,449<br>**1,449**<br>**Totalat**<br>**31 March**<br>**2021**<br>**£000**<br>1,145<br>1,449<br>460<br>3,774<br>1,000<br>**7,828**|
|---|---|



## 

## 

|Issued share capital<br>Turnover<br>Expenditure<br>Total Assets<br>Total Liabilities<br>Shareholders'Funds||**2022**<br>**2021**<br>£<br>£<br>2<br>2|
|---|---|---|
|||764,387<br>429,503<br>346,244<br>177,668|
||||
|||468,945<br>322,156|
|||468,506<br>321,717|
|||439<br>439|





## 

## 

|RecoverableTax&Accrued income<br>Other Debtors|**2022**<br>**£000**<br>**Group**<br>587<br>34<br>**2022**<br>**£000**<br>**Charity**<br>678<br>171<br>**2021**<br>**£000**<br>**Group**<br>256<br>17<br>**2021**<br>**£000**<br>**Charity**<br>366<br>82|
|---|---|
||**621**<br>**849**<br>**273**<br>**448**|



## 

|Bank current and deposit account balances|**2022**<br>**Group**<br>**£000**<br>2,959<br>**2,959**<br>**2022**<br>**Charity**<br>**£000**<br>2,779<br>**2,779**|**2021**<br>**Group**<br>**£000**<br>2,026<br>**2,026**<br>**2021**<br>**Charity**<br>**£000**<br>1,906<br>**1,906**|
|---|---|---|



## 

|Falling duewithinone year:<br>Amountowedtosubsidiary<br>Taxationandsocial security costs<br>AmountowedtoAlderHeyNHSTrust (recharged)<br>AmountowedtoAlderHeyNHSTrust (accrued grant)<br>Pension contributions due<br>Other creditors and accruals|**2022**<br>**Group**<br>**£000**<br>21<br>82<br>4,474<br>12<br>174<br>**4,763**|**2022**<br>**Charity**<br>**£000**<br>21<br>82<br>4,474<br>12<br>143<br>**4,732**|**2021**<br>**Group**<br>**£000**<br>20<br>44<br>1,546<br>12<br>32<br>**1,654**|**2021**<br>**Charity**<br>**£000**<br>19<br>44<br>1,546<br>12<br>28<br>**1,649**|
|---|---|---|---|---|





## 

## 

|**Fund**<br>John Lennon Research Fund<br>Neonatal CapitalFund<br>Projects Fund<br>Alder CentreFund<br>Burns Unit Fund<br>Leukaemia Research Fund<br>IntensiveCareFund<br>Oncology Fund<br>Cancer Patients Fund<br>NephrologyFund<br>Neonatal Fund<br>Tier 4MentalHealth<br>Cardiac Fund<br>Cardiac Surgery Fund<br>Others (55)<br>**Total**|**Balanceat**<br>**Incoming**<br>**Resources**<br>**Gains**<br>**Balance**<br>**31 March**<br>**Resources**<br>**Expended**<br>&<br>**31 March**<br>**2021**<br>**Losses**<br>**2022**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>168<br>168<br>382<br>382<br>554<br>1,105<br>(851)<br>808<br>57<br>52<br>(50)<br>59<br>61<br>2<br>(2)<br>61<br>172<br>172<br>119<br>5<br>(3)<br>121<br>213<br>43<br>(90)<br>166<br>70<br>1<br>71<br>97<br>(73)<br>24<br>52<br>29<br>81<br>250<br>547<br>(797)<br>129<br>22<br>(133)<br>18<br>226<br>2<br>(50)<br>178<br>731<br>164<br>(150)<br>745|
|---|---|
||**2,899**<br>**2,354**<br>**(2,199)**<br>**3,054**|





## 

## 

||**Balanceat**|**Balanceat**|**Incoming**|**Resources**|**Gains**|**Transfers**|**Balance**|
|---|---|---|---|---|---|---|---|
||**31**|**March**|**Resources**|**Expended**|&|**£000**|**31March**|
|||**2021**|**£000**|**£000**|**Losses**||**2022**|
|||**£000**|||**£000**||**£000**|
|Alder Hey General||3,384|4,279|(3,268)|252|(953)|3,694|
|Purpose Fund||||||||
|Neonatal Capital||||||1,000|1,000|
|Designated Fund||||||||
|Mental Health||2,250||(2,203)||(47)||
|Designated Fund||||||||
|**Total**||**5,634**|**4,279**|**(5,471}**|**252**||**4,694**|
|**UnrestrictedFunds**- **Charity**||||||||
||**Balanceat**||**Incoming**|**Resources**|**Gains**&|**Transfers**|**Balance**|
||**31**|**March**|**Resources**|**Expended**|**Losses**||**at31**|
|||**2021**|**£000**|**£000**|**£000**|**£000**|**March**|
|||**£000**|||||**2022**|
||||||||**£000**|
|Alder Hey General||3,384|3,933|(2,922)|252|(953)|3,694|
|Purpose Fund||||||||
|Neonatal Capital||||||1,000|1,000|
|Designated Fund||||||||
|MentalHealth||2,250||(2,203)||(47)||
|Designated Fund||||||||
|**Total**||**5,634**|**3,933**|**(5,125}**|**252**||**4,694**|





## 

## 

|**Restricted Funds**<br>**Fund**<br>John Lennon ResearchFund<br>Alder Centre CapitalFund<br>Projects Fund<br>Alder Centre Fund<br>Burns Unit Fund<br>Leukaemia ResearchFund<br>Oncology Fund<br>Intensive CareFund<br>Cancer PatientsFund<br>NephrologyFund<br>Neonatal Fund<br>Tier 4MentalHealth<br>Others (55)|**Balanceat**<br>**Incoming**<br>**Resources**<br>**Gains**<br>**Balanceat**<br>**31March**<br>**Resources**<br>**Expensed**<br>&<br>**31March**<br>**2020**<br>**Losses**<br>**2021**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>168<br>168<br>629<br>2<br>(631)<br>684<br>615<br>(745)<br>554<br>51<br>24<br>(18)<br>57<br>63<br>(2)<br>61<br>171<br>1<br>172<br>131<br>64<br>18<br>213<br>111<br>2<br>6<br>119<br>71<br>(1)<br>70<br>95<br>3<br>(1)<br>97<br>91<br>1<br>(40)<br>52<br>105<br>145<br>250<br>960<br>146<br>(20)<br>1,086|
|---|---|
||**3,330**<br>**1,003**<br>**(1,434)**<br>**2,899**|





## 

## 

## 

|Alder Hey General Purpose<br>Fund<br>COVID-19DesignatedFund<br>Mental Health Designated<br>Fund<br>Total<br>nrestricted Funds - Charity<br>Alder Hey General Purpose<br>Fund<br>COVID-19 DesignatedFund<br>Mental Health Designated<br>Fund<br>Total|Balanceat<br>Incoming<br>Resources<br>Gains &<br>Transfers<br>**Balanceat**<br>31March<br>Resources<br>**Expended**<br>Losses<br>. March 2021<br>**2020**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>3,860<br>3,726<br>(2,618)<br>666<br>(2,250)<br>3,384<br>1,815<br>(1,815)<br>2,250<br>2,250<br>**5,675**<br>**3,726**<br>**(4,433}**<br>**666**<br>**5,634**<br>Balanceat<br>Incoming<br>Resources<br>Gains &<br>Transfers<br>Balanceat<br>31March<br>Resources<br>Expended<br>Losses<br>March 2021<br>**2020**<br>**£000**<br>£000<br>£000<br>£000<br>£000<br>£000<br>3,239<br>4,169<br>(2,440)<br>666<br>(2,250)<br>3,384<br>1,815<br>(1,815)<br>2,250<br>2,250|
|---|---|
||**5,054**<br>**4,169**<br>**(4,255}**<br>**666**<br>**5,634**|



## 

## 

|Asat31 March 2022<br>Charity:<br>Unrestricted<br>Restricted<br>Total<br>Group:<br>Unrestricted<br>Restricted<br>Total||**Fixed**<br>Current<br>Current<br>Long Term<br>Net<br>Assets<br>Assets<br>Liabilities<br>Liabilities<br>Assets<br>£000<br>£000<br>£000<br>£000<br>£000<br>4,076<br>3,628<br>3,010<br>4,654<br>4,776<br>1,722<br>3,054|
|---|---|---|
|||**8,852**<br>**3,628**<br>**4,732**<br>**7,748**<br>4,119<br>3,616<br>3,041<br>4,694<br>4,776<br>1,722<br>3,054|
||||
|||**8,895**<br>**3,616**<br>**4,763**<br>**7,748**|





## 

|**Asat 31 March 2021**<br>**Charity:**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**Group:**<br>**Unrestricted**<br>**Restricted**<br>**Total**||**Fixed**<br>**Current**<br>**Current**<br>**LongTerm**<br>**Net**<br>**Assets**<br>**Assets**<br>**Liabilities**<br>**Liabilities**<br>**Assets**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>**£000**<br>5,959<br>448<br>773<br>5,634<br>1,869<br>1,906<br>876<br>2,899|
|---|---|---|
|||**7,828**<br>**2,354**<br>**1,649**<br>**8,533**<br>5,964<br>448<br>778<br>5,634<br>1,890<br>1,885<br>876<br>2,899|
||||
|||**7,854**<br>**2,333**<br>**1,654**<br>**8,533**|



## 

## 

## 

## 

## 



## 

## 

